Fetal marrow suppression after maternal chemotherapy for leukaemia.
Open Access
- 1 November 1994
- journal article
- case report
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 71 (3) , F209-F210
- https://doi.org/10.1136/fn.71.3.f209
Abstract
A preterm baby, whose mother received chemotherapy for acute leukaemia during pregnancy, required intensive care because of profound anaemia and neutropenia. Haemopoietic progenitor cell studies showed fetal marrow suppression. Those caring for such mothers and babies should know the possible serious effects chemotherapy for malignancies can have on a developing fetus. Long term follow up of the baby is imperative.Keywords
This publication has 5 references indexed in Scilit:
- Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursThe Lancet, 1991
- Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 childrenAmerican Journal of Hematology, 1991
- Transplacental effects of maternal cancer chemotherapy. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemiaClinical and Laboratory Haematology, 1989
- Erythroid progenitors (BFU-e and CFU-e) in acute leukaemia.Journal of Clinical Pathology, 1979